Outcomes of early catheter ablation for ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized trials

被引:0
作者
Shalganov, Tchavdar [1 ]
Stoyanov, Milko [1 ]
Traykov, Vassil [2 ]
机构
[1] Natl Heart Hosp, Dept Cardiol, Sofia, Bulgaria
[2] Tokuda Hosp, Dept Cardiol, Acibadem City Clin, Sofia, Bulgaria
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
systematic review; ventricular tachycardia (VT); catheter ablation; all-cause mortality; quality of life; LONG-TERM OUTCOMES; ISCHEMIC CARDIOMYOPATHY; ELECTRICAL STORM; SHOCKS; IMPACT; VT;
D O I
10.3389/fcvm.2022.1063147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Catheter ablation (CA) for ventricular tachycardia (VT) can improve outcomes in patients with ischemic cardiomyopathy. Data on patients with non-ischemic cardiomyopathy are scarce. The purpose of this systematic review and meta-analysis is to compare early CA for VT to deferred or no ablation in patients with ischemic or non-ischemic cardiomyopathy.Methods and results: Studies were selected according to the following PICOS criteria: patients with structural heart disease and an implantable cardioverter-defibrillator (ICD) for VT, regardless of the antiarrhythmic drug treatment; intervention-early CA; comparison-no or deferred CA; outcomes-any appropriate ICD therapy, appropriate ICD shocks, all-cause mortality, VT storm, cardiovascular mortality, cardiovascular hospitalizations, complications, quality of life; published randomized trials with follow-up >= 12 months. Random-effect meta-analysis was performed. Outcomes were assessed using aggregate study-level data and reported as odds ratio (OR) or mean difference with 95% confidence intervals (CIs). Stratification by left ventricular ejection fraction (LVEF) was also done. Eight trials (n = 1,076) met the criteria. Early ablation was associated with reduced incidence of ICD therapy (OR 0.53, 95% CI 0.33-0.83, p = 0.005), shocks (OR 0.52, 95% CI 0.35-0.77, p = 0.001), VT storm (OR 0.58, 95% CI 0.39-0.85, p = 0.006), and cardiovascular hospitalizations (OR 0.67, 95% CI 0.49-0.92, p = 0.01). All-cause and cardiovascular mortality, complications, and quality of life were not different. Stratification by LVEF showed a reduction of ICD therapy only with higher EF (high EF OR 0.40, 95% CI 0.20-0.80, p = 0.01 vs. low EF OR 0.62, 95% CI 0.34-1.12, p = 0.11), while ICD shocks (high EF OR 0.54, 95% CI 0.25-1.15, p = 0.11 vs. low EF OR 0.50, 95% CI 0.30-0.83, p = 0.008) and hospitalizations (high EF OR 0.95, 95% CI 0.58-1.58, p = 0.85 vs. low EF OR 0.58, 95% CI 0.40-0.82, p = 0.002) were reduced only in patients with lower EF.Conclusion: Early CA for VT in patients with structural heart disease is associated with reduced incidence of ICD therapy and shocks, VT storm, and hospitalizations. There is no impact on mortality, complications, and quality of life. (The review protocol was registered with INPLASY on June 19, 2022, #202260080).
引用
收藏
页数:18
相关论文
共 36 条
  • [1] Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients
    Acosta, Juan
    Cabanelas, Nuno
    Penela, Diego
    Fernandez-Armenta, Juan
    Andreu, David
    Borras, Roger
    Korshunov, Viatcheslav
    Cabrera, Mario
    Vasanelli, Francesca
    Arbelo, Elena
    Guasch, Eduard
    Martinez, Mikel
    Tolosana, Jose M.
    Mont, Lluis
    Berruezo, Antonio
    [J]. EUROPACE, 2017, 19 (06): : 976 - 982
  • [2] Al-Khatib SM, 2018, CIRCULATION, V138, pE272, DOI [10.1161/CIR.0000000000000548, 10.1161/CIR.0000000000000549]
  • [3] Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial
    Al-Khatib, Sana M.
    Daubert, James P.
    Anstrom, Kevin J.
    Daoud, Emile G.
    Gonzalez, Mario
    Saba, Samir
    Jackson, Kevin P.
    Reece, Tammy
    Gu, Joan
    Pokorney, Sean D.
    Granger, Christopher B.
    Hess, Paul L.
    Mark, Daniel B.
    Stevenson, William G.
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2015, 26 (02) : 151 - 157
  • [4] [Anonymous], GRADEpro Guideline Development Tool Software
  • [5] Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia
    Arenal, Angel
    Avila, Pablo
    Jimenez-Candil, Javier
    Tercedor, Luis
    Calvo, David
    Arribas, Fernando
    Fernandez-Portales, Javier
    Luis Merino, Jose
    Hernandez-Madrid, Antonio
    Fernandez-Aviles, Francisco J.
    Berruezo, Antonio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (15) : 1441 - 1453
  • [6] Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy
    Basu-Ray, Indranill
    Khanra, Dibbendhu
    Shah, Sumit K.
    Mukherjee, Anindya
    Char, Sudhanva V.
    Jain, Bhavna
    Bunch, T. Jared
    Gold, Michael
    Adeboye, Adedayo A.
    Saeed, Mohammad
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (01): : 54 - 62
  • [7] Management of patients receiving implantable cardiac defibrillator shocks
    Braunschweig, Frieder
    Boriani, Giuseppe
    Bauer, Alexander
    Hatala, Robert
    Herrmann-Lingen, Christoph
    Kautzner, Josef
    Pedersen, Susanne S.
    Pehrson, Steen
    Ricci, Renato
    Schalij, Martin J.
    [J]. EUROPACE, 2010, 12 (12): : 1673 - 1690
  • [8] Catheter ablation for the treatment of electrical storm in patients with Implantable cardioverter-defibrillators - Short- and long-term outcomes in a prospective single-center study
    Carbucicchio, Corrado
    Santamaria, Matteo
    Trevisi, Nicola
    Maccabelli, Giuseppe
    Giraldi, Francesco
    Fassini, Gaetano
    Riva, Stefania
    Moltrasio, Massimo
    Cireddu, Manuela
    Veglia, Fabrizio
    Della Bella, Paolo
    [J]. CIRCULATION, 2008, 117 (04) : 462 - 469
  • [9] Implantable cardioverter defibrillators and their role in heart failure progression
    Cevik, Cihan
    Perez-Verdia, Alejandro
    Nugent, Kenneth
    [J]. EUROPACE, 2009, 11 (06): : 710 - 715
  • [10] Cronin EM, 2019, EUROPACE, V21, P1143, DOI 10.1093/europace/euz132